Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular

Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Leal,Bryan, Torres,Héctor, Roco,Ángela, Román,Ricardo, Rojo,Mario, Nieto,Elena, Quiñones,Luis
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2021
Materias:	Acenocoumarol Anticoagulants Atrial Fibrillation Pharmaceutical Services
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500724
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872021000500724
record_format	dspace
spelling	oai:scielo:S0034-988720210005007242021-11-03Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricularLeal,BryanTorres,HéctorRoco,ÁngelaRomán,RicardoRojo,MarioNieto,ElenaQuiñones,Luis Acenocoumarol Anticoagulants Atrial Fibrillation Pharmaceutical Services Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates. Proper pharmaceutical care improves TRT. Aim: To evaluate the impact of pharmaceutical care in patients with AF treated with acenocoumarol. Material and Methods: We studied 41 patients using acenocoumarol for AF aged 71 ± 11 years (43% women). They received pharmaceutical counseling during 12 weeks. TRT was calculated retrospectively for the year before counseling and prospectively during the intervention period. Results: After receiving pharmaceutical counseling TRT improved from 29% at baseline to 46% at the end of the intervention (p < 0.01). After pharmaceutical care, the adherence of patients to drug treatment improved from 27% at baseline to 85% at the end of the study. The user satisfaction survey of the pharmaceutical care received showed a high degree of patient satisfaction. Conclusions: Pharmaceutical care in patients with oral anticoagulant treatment improves TRT of anticoagulation. It is accepted and positively evaluated by patients.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.5 20212021-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500724es10.4067/s0034-98872021000500724
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Acenocoumarol Anticoagulants Atrial Fibrillation Pharmaceutical Services
spellingShingle	Acenocoumarol Anticoagulants Atrial Fibrillation Pharmaceutical Services Leal,Bryan Torres,Héctor Roco,Ángela Román,Ricardo Rojo,Mario Nieto,Elena Quiñones,Luis Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
description	Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates. Proper pharmaceutical care improves TRT. Aim: To evaluate the impact of pharmaceutical care in patients with AF treated with acenocoumarol. Material and Methods: We studied 41 patients using acenocoumarol for AF aged 71 ± 11 years (43% women). They received pharmaceutical counseling during 12 weeks. TRT was calculated retrospectively for the year before counseling and prospectively during the intervention period. Results: After receiving pharmaceutical counseling TRT improved from 29% at baseline to 46% at the end of the intervention (p < 0.01). After pharmaceutical care, the adherence of patients to drug treatment improved from 27% at baseline to 85% at the end of the study. The user satisfaction survey of the pharmaceutical care received showed a high degree of patient satisfaction. Conclusions: Pharmaceutical care in patients with oral anticoagulant treatment improves TRT of anticoagulation. It is accepted and positively evaluated by patients.
author	Leal,Bryan Torres,Héctor Roco,Ángela Román,Ricardo Rojo,Mario Nieto,Elena Quiñones,Luis
author_facet	Leal,Bryan Torres,Héctor Roco,Ángela Román,Ricardo Rojo,Mario Nieto,Elena Quiñones,Luis
author_sort	Leal,Bryan
title	Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_short	Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_full	Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_fullStr	Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_full_unstemmed	Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
title_sort	impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
publisher	Sociedad Médica de Santiago
publishDate	2021
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500724
work_keys_str_mv	AT lealbryan impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular AT torreshector impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular AT rocoangela impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular AT romanricardo impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular AT rojomario impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular AT nietoelena impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular AT quinonesluis impactodelaatencionfarmaceuticaenlacalidaddeltratamientoconacenocumarolenpacientesconfibrilacionauricular
_version_	1718437204009680896

Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular

Ejemplares similares